OncoMatch/Clinical Trials/NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Is NCT06056830 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies 64Cu-SAR-bisPSMA for prostate cancer.
Treatment: 64Cu-SAR-bisPSMA — The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Prostate Cancer
Disease stage
Required: Stage ≥T3A (NCCN)
Grade: ≥4 (Grade Group)
High-risk or greater PC defined by National Comprehensive Cancer Network Guidelines Version 1.202327 (clinical stage ≥T3a, or Grade Group ≥4, or PSA >20 ng/mL)
Demographics
Prior therapy
Cannot have received: high energy (>300 KeV) gamma-emitting radioisotope
Exception: within 5 physical half-lives prior to Day 1
Administration of any high energy (>300 KeV) gamma-emitting radioisotope within 5 physical half-lives prior to Day 1
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- University of Alabama Birmingham Hospital · Birmingham, Alabama
- Mayo Clinic- Phoenix · Phoenix, Arizona
- Urology Group of Southern California · Los Angeles, California
- Greater Los Angeles VA Medical Center · Los Angeles, California
- Stanford University Medical Center · Stanford, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT06056830 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
What disease stage is eligible?
Stage ≥T3A is required.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages